Nephros (NASDAQ:NEPH – Get Free Report) is expected to be releasing its earnings data before the market opens on Wednesday, March 5th. Analysts expect Nephros to post earnings of ($0.01) per share and revenue of $3.57 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
Nephros Stock Performance
Shares of NASDAQ NEPH opened at $1.41 on Tuesday. The stock has a fifty day moving average price of $1.55 and a two-hundred day moving average price of $1.60. The firm has a market cap of $14.87 million, a P/E ratio of -15.67 and a beta of 1.19. Nephros has a 1 year low of $1.36 and a 1 year high of $3.19.
Wall Street Analysts Forecast Growth
Separately, Benchmark reaffirmed a “speculative buy” rating and set a $5.00 price target on shares of Nephros in a research note on Tuesday, November 12th.
About Nephros
Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
Further Reading
- Five stocks we like better than Nephros
- What is a Bond Market Holiday? How to Invest and Trade
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- How to Evaluate a Stock Before BuyingÂ
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What is a penny stock? A comprehensive guide
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.
